| P2093 | author name string | Emma Mercer | |
| | Amyn M Rojiani | |
| | Dietmar W Siemann | |
| | Sharon Lepler | |
| P2860 | cites work | In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug | Q28754742 |
| | Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors | Q33182196 |
| | Targeting tumor blood vessels: an adjuvant strategy for radiation therapy | Q34060827 |
| | Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice | Q35994321 |
| | Recovery of cell subpopulations from human tumour xenografts following dissociation with different enzymes | Q36027441 |
| | Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs | Q36115429 |
| | Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours | Q36450490 |
| | Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid | Q41337809 |
| | Prediction of tumour sensitivity to 4-hydroperoxycyclophosphamide by a glutathione-targeted assay | Q42014522 |
| | Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid | Q43768728 |
| | Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy. | Q54113704 |
| | The Current Status of Targeting Tumour Vasculature as a Means of Cancer Therapy: An Overview | Q67696297 |
| | Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids | Q68191227 |
| | Potentiation of combination chemotherapy by nitroheterocyclics | Q68436363 |
| | Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid | Q72280934 |
| | Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872 | Q72338181 |
| | Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid | Q72465089 |
| | Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid | Q73267110 |
| | Potentiation of cisplatin activity by the bioreductive agent tirapazamine | Q74820554 |
| | The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors | Q77654113 |
| | Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid | Q77654115 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy | |
| P478 | volume | 99 | |